Preeclampsia (PE) or gestational hypertension (GH) is a common medical problem that is associated with a range of maternal and fetal complications, including kidney dysfunction, hepatic injury, pulmonary edema, eclampsia, fetal growth restriction (FGR), and stillbirth.
1,2 Evidence from epidemiologic studies shows that PE or GH affects 2% to 10% of all pregnancies worldwide and is associated with some neurodevelopmental disorders in offspring, especially complicated by FGR.
1,3,4